Additional agents active against MRSA not available in Canada
| AGENT | ROUTE | STATUS (AT TIME OF WRITING) |
|---|---|---|
| Tedizolid | Oral or IV | Received NOC; not yet marketed |
| Ceftobiprole medocaril | IV | Received NOC; never marketed |
| Ceftaroline | IV | Not available |
| Dalbavancin | IV (weekly) | Not available |
| Oritavancin | IV (1-time dose) | Not available |
IV—intravenous, MRSA—methicillin-resistant Staphylococcus aureus, NOC—Health Canada Notice of Compliance.